Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

EIP Pharma reports mixed results from neflamapimod Alzheimer’s trial

Neflamapimod is being developed to treat Alzheimer’s, dementia with Lewy bodies and Huntington’s disease with cognitive dysfunction. Credit: kalhh from Pixabay.